Clinical Trial Update: The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation [Phase 4]

View source ↗

Summary

A completed Phase 4 trial from the Medical University of Vienna evaluated the role of the P2Y12 receptor in tissue factor–induced coagulation. Sepsis was among …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Medical University of Vienna | Conditions: Healthy Volunteers, Sepsis | Phase 4 | Status: COMPLETED